Daxor Corporation (DXR) vs Stereotaxis Inc. (STXS)

Daxor Corporation and Stereotaxis Inc. are both Medical Instruments & Supplies companies. Stereotaxis Inc. is the larger, with a market value of $105.2M against $50.4M — 2.1× the size. Stereotaxis Inc. has negative trailing earnings, so its P/E is not meaningful; Daxor Corporation trades at 4.0×. Stereotaxis Inc. grew revenue faster over the last twelve months: −5.46% against −52.1%. Stereotaxis Inc. has the higher net margin (−78.5% vs −251.9%) and the lower return on invested capital (−203.6% vs 0.00%). Across the 16 metrics below, Daxor Corporation leads on 10 and Stereotaxis Inc. on 6.

Valuation

Metric DXR STXS Medical Instruments & Supplies median
P/E 3.98 n/m 30.84
P/S n/m 3.69 2.54
P/B 1.26 9.07 2.36
Price to free cash flow n/m n/m 23.46
EV/EBITDA n/m n/m 14.70
EV/Sales (12.40) 3.45 2.78
Earnings yield 25.12% (21.62%) 0.25%
Free cash flow yield (19.68%) (13.96%) 0.57%

Profitability

Metric DXR STXS Medical Instruments & Supplies median
Gross margin 0.00% 55.57% 53.46%
Operating margin 0.00% (75.68%) 2.26%
Net margin (251.91%) (78.45%) 0.16%
Free cash flow margin 224.51% (51.56%) 4.10%
Return on equity 37.62% (344.36%) 0.00%
Return on assets 35.90% (48.76%) 0.00%
Return on invested capital 0.00% (203.58%) 0.13%

Growth

Metric DXR STXS Medical Instruments & Supplies median
Revenue growth (TTM) (52.06%) (5.46%) 8.97%
EPS growth (last fiscal year) 7.63% 16.67% 6.51%
Revenue growth, 5-year CAGR 0.00% 3.99% 8.85%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DXR STXS Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.10
Current ratio 1.66 1.42 2.42
Net debt to EBITDA 0.00 0.65 0.97

Dividend

Metric DXR STXS Medical Instruments & Supplies median
Dividend yield — — 1.03%
Payout ratio — — 0.25

Size

Metric DXR STXS Medical Instruments & Supplies median
Market cap 50.40m 105.21m 1.64b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack